Skip to main content
Equibles

Schonfeld Strategic Advisors LLC

Position in PMCB — PharmaCyte Biotech, Inc.

CIK 1665241 NEW YORK, NY
Back to PMCB Full portfolio

Position in PMCB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,733
+$2,762 QoQ
Shares Held
26,926
-0.3% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 30 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMCB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. PMCB ranks #130 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 697,586 $66,096,273
2 AGIO
Agios Pharmaceuticals, Inc.
 520,083 $19,300,280
3 JAZZ
Jazz Pharmaceuticals plc
 77,272 $18,620,233
4 VRDN
Viridian Therapeutics, Inc.\DE
 793,508 $14,576,741
5 MBX
MBX Biosciences, Inc.
 248,670 $13,726,584
6 XENE
Xenon Pharmaceuticals Inc.
 227,330 $13,721,638
7 PTCT
Ptc Therapeutics, Inc.
 147,425 $12,025,457
8 INSM
INSMED Inc
 104,378 $11,128,782

All Filings in PMCB

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,733 26,926
2026-03-31 $17,971 27,009
2025-12-31 $18,952 26,178
2025-09-30 $25,403 26,200
2025-06-30 $28,558 26,200
2025-03-31 $31,875 25,500
2024-12-31 $40,349 25,700
2024-09-30 $49,469 25,900
2024-06-30 $46,452 23,700
2024-03-31 $55,695 23,500
2023-12-31 $50,112 23,200
2023-09-30 $48,930 23,300
2023-06-30 $67,210 23,500
2023-03-31 $69,840 24,000
2022-12-31 $73,836 25,200
2022-09-30 $59,520 24,800
2022-06-30 $58,688 26,200
2022-03-31 $60,490 26,300
2021-12-31 $76,000 30,400
2021-09-30 $279,594 88,200